gp130 cytokine family and bone cells

被引:155
作者
Heymann, D
Rousselle, AV
机构
[1] Fac Med, Lab Physiopathol Resorpt Osseuse, F-44035 Nantes 1, France
[2] Fac Med, Lab Histol & Embryol, F-44035 Nantes 01, France
关键词
gp130; IL-6; IL-11; leukaemia inhibitory factor; ciliary neurotrophic factor; oncostatin M; cardiotrophin-1; bone; osteoblast; osteoclast;
D O I
10.1006/cyto.2000.0747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone tissue is continually being remodelled according to physiological circumstances, Two main cell populations (osteoblasts and osteoclasts) are involved in this process, and cellular activities (including cell differentiation) are modulated by hormones, cytokines and growth factors, Within the last 20 years, many factors involved in bone tissue metabolism have been found to be closely related to the inflammatory process. More recently, a cytokine family sharing a common signal transducer (gp130) had been identified, which appears to be a key factor in bone remodelling, This family includes interleukin 6, interleukin 11, oncostatin M, leukaemia inhibitory factor, ciliary neurotrophic factor and cardiotrophin-1. This paper provides an exhaustive review of recent knowledge on the involvement of gp130 cytokine family in bone cell (osteoblast, osteoclast, etc.) differentiation/activation and in osteoarticular pathologies. (C) 2000 Academic Press.
引用
收藏
页码:1455 / 1468
页数:14
相关论文
共 219 条
[1]  
ABE E, 1988, J BONE MINER RES, V3, P635
[2]   Mode of action of interleukin-6 on mature osteoclasts.: Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption [J].
Adebanjo, OA ;
Moonga, BS ;
Yamate, T ;
Sun, L ;
Minkin, C ;
Abe, E ;
Zaidi, M .
JOURNAL OF CELL BIOLOGY, 1998, 142 (05) :1347-1356
[3]  
AHTOMONTE L, 1992, CLIN RHEUMATOL, V11, P202
[4]   The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway [J].
Akatsu, T ;
Ono, K ;
Katayama, Y ;
Tamura, T ;
Nishikawa, M ;
Kugai, N ;
Yamamoto, M ;
Nagata, N .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (03) :400-408
[5]   OSTEOBLASTS DISPLAY RECEPTORS FOR AND RESPONSES TO LEUKEMIA-INHIBITORY FACTOR [J].
ALLAN, EH ;
HILTON, DJ ;
BROWN, MA ;
EVELY, RS ;
YUMITA, S ;
METCALF, D ;
GOUGH, NM ;
NG, KW ;
NICOLA, NA ;
MARTIN, TJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (01) :110-119
[6]  
Aman MJ, 1996, EXP HEMATOL, V24, P863
[7]   PRODUCTION OF HUMAN INTERLEUKIN FOR DA CELLS (HILDA) LEUKEMIA INHIBITORY FACTOR (LIF) BY ACTIVATED MONOCYTES [J].
ANEGON, I ;
MOREAU, JF ;
GODARD, A ;
JACQUES, Y ;
PEYRAT, MA ;
HALLET, MM ;
WONG, G ;
SOULILLOU, JP .
CELLULAR IMMUNOLOGY, 1990, 130 (01) :50-65
[8]   Current concepts review - Cellular biology of bone-resorbing cells [J].
Athanasou, NA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1996, 78A (07) :1096-1112
[9]   Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells [J].
Barille, S ;
Akhoundi, C ;
Collette, M ;
Mellerin, MP ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 1997, 90 (04) :1649-1655
[10]  
Barton BE, 1996, MED RES REV, V16, P87, DOI 10.1002/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO